- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Mankind Pharma Limited — Updates, 22-08-2026: General Updates
22-08-2026 | 02:01 pm
22-08-2026 | 02:01 pm
Mankind Pharma's independent ESG rating by CRISIL improved to 'Strong' (64) from 'Adequate' (57), with its Core ESG rising to 71. This reflects enhanced sustainability practices, potentially boosting long-term investor appeal.
No comments yet. Be the first to comment!